USE OF EDG RECEPTOR BINDING AGENTS IN CANCER

摘要

Provided is a method for treating solid tumors, e. g tumor invasiveness, and particularly inhibiting or controlling deregulated angiogenesis, using a sphingosine-1-phosphate receptor agonist, optionally in combination with a chemotherapeutic agent. The invention also comprises a combination of a sphingosine-1-phosphate receptor agonist with a chemotherapeutic agent.